LA MALATTIA DIVERTICOLARE SEGNALA UN AUMENTO DEL RISCHIO DI CANCRO : + 33% (COLON, FEGATO, PANCREAS E POLMONE). UN EDITORIALE IMPORTANTE DAL “J Natl Cancer Inst .” (FREE)

Diverticular disease and cancer risk: More than a gut feeling  Veronika Fedirko et al. Diverticular disease of the colon is among the most common gastrointestinal disorders in Western countries. It is a clinically significant and symptomatic diverticulosis, which is defined by the presence of a pouch-like protrusion of the colonic wall known as diverticula. Diverticular…

MODULARE IL MICROBIOTA NELLE IBD: PRE-,PRO-, SYN-, O POSTBIOTICI? .UNA REVIEW DA “AM. J. OF GASTROINTESTINAL AND LIVER PHYSIOLOGY”(FREE)

Inflammatory bowel disease therapeutic strategies by modulation of the microbiota: how and when to introduce pre-, pro-, syn- or postbiotics? Amélie Lê et al. ABSTRACT Inflammatory bowel diseases (IBD), a heterogeneous group of inflammatory conditions that 34 encompass both ulcerative colitis and Crohn’s disease, represent a major public health concern. The etiology of IBD is…

PPI RIDUCONO IL RISCHIO DI EMORRAGIA DIGESTIVA SOTTO ANTICOAGULANTI : UN’OTTIMA META-ANALISI. – 33%. DA “AMERICAN JOURNAL OF MEDICINE”

Association of Antisecretory Drugs with Upper Gastrointestinal Bleeding in Patients Using Oral Anticoagulants: A Systematic Review and Meta-Analysis Jacob E. Kurlande et al. Abstract Background The role of antisecretory drugs for the prevention of upper gastrointestinal bleeding in patients using anticoagulants is unclear. We investigated this question in a systematic review and meta-analysis. Methods We…

TRA I NUOVI ANTICOAGULANTI APIXABAN INDUCE MENO EMORRAGIA DIGESTIVA ! DA “ANNALS OF INTERNAL MEDICINE”

Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation A Multinational Population-Based Cohort Study Wallis C.Y. Lau, et al Background: Current guidelines recommend using direct oral anticoagulants (DOACs) over warfarin in patients with atrial fibrillation (AF), but head-to-head trial data do not exist to guide the choice of DOAC.…

MICROBIOTA ED ASSE GUT-BRAIN : NEUROSCIENZA NUTRIZIONALE. UNA REVISIONE DA “NUTRITIONAL NEUROSCIENCE”

The microbiome-gut-brain axis in nutritional neuroscience Harriët Schellekens et al. ABSTRACT Emerging evidence is highlighting the microbiome as a key regulator of the effect of nutrition on gut-brain axis signaling. Nevertheless, it is not yet clear whether the impact of nutrition is moderating the microbiota-gut-brain interaction or if diet has a mediating role on microbiota…

MICROBIOTA E TEMPO DI TRANSITO ! UNA RIFLESSIONE DA “GUT” MOLTO RILEVANTE (NON ANCORA EVIDENCE-BASED) (FREE)

Advancing human gut microbiota research by considering gut transit time Nicola Procházková et al. Abstract Accumulating evidence indicates that gut transit time is a key factor in shaping the gut microbiota composition and activity, which are linked to human health. Both population-wide and small-scale studies have identified transit time as a top covariate contributing to…